Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer.

Support Care Cancer · 2022 · PMC9046346 · PMID 35292848

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, CTCAE, VAS, and CiTAS scores showed a trend toward improvement in dysgeusia in the polaprezinc group, but not the zinc acetate hydrate group, compared with the no intervention group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.